Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials

IMPORTANCE: Flortaucipir positron emission tomography (PET) scans, rated with a novel, US Food and Drug Administration–approved, clinically applicable visual interpretation method, provide valuable information regarding near-term clinical progression of patients with Alzheimer disease (AD) or mild c...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Neurol
Main Authors: Lu, Ming, Pontecorvo, Michael J., Devous, Michael D., Arora, Anupa K., Galante, Nicholas, McGeehan, Anne, Devadanam, Catherine, Salloway, Stephen P., Doraiswamy, P. Murali, Curtis, Craig, Truocchio, Stephen P., Flitter, Matthew, Locascio, Tricia, Devine, Marybeth, Zimmer, Jennifer A., Fleisher, Adam S., Mintun, Mark A.
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2021
Assuntos:
Original Investigation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7885097/
https://ncbi.nlm.nih.gov/pubmed/33587110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2020.5505
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares